Thursday, 20 December 2018

Supernus Pharma's ADHD drug meets main goal in late-stage trial

Supernus Pharmaceuticals Inc said on Thursday its drug for attention deficit hyperactivity disorder met the main goal in a late-stage study testing in adolescents.


No comments:

Post a Comment